Over a month ago
Hot Stocks
Synaptics (SYNA)…
Synaptics (SYNA) announced that it added Lori Stahl as chief people officer and Vikram Gupta as SVP and GM of IoT Processors and chief product officer. As chief people officer, Stahl will be responsible for executing Synaptics' human resource, or HR, strategy and employee programs worldwide. Stahl comes with 25 years of experience in almost all human resources disciplines across the technology, insurance, and renewable energy industries. Prior to Synaptics, she was chief people officer at Vocera Communications. In his role as SVP and GM of IoT Processors and chief product officer, Gupta will lead Synaptics' embedded and edge processing division, or EEPD. Gupta joins Synaptics from Infineon Technologies, where he served as SVP and GM of IoT compute and wireless business lines.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 11/14/22 Infineon, Stellantis sign memorandum of understanding for silicon carbide chips 08/23/22 II-VI signs multi-year contract to supply Infineon with SiC substrates 02/03/23 Craig-Hallum Synaptics price target raised to $150 from $120 at Craig-Hallum 02/03/23 Susquehanna Synaptics price target raised to $145 from $115 02/03/23 Oppenheimer Synaptics downgraded to Perform from Outperform at Oppenheimer 02/03/23 TD Cowen Synaptics price target raised to $150 from $100 at Cowen 02/06/23 Deutsche Bank Infineon price target raised to EUR 44 from EUR 42 at Deutsche Bank 02/03/23 Barclays Infineon price target raised to EUR 48 from EUR 47 at Barclays 02/03/23 Credit Suisse Infineon price target raised to EUR 49.10 from EUR 47.40 at Credit Suisse 02/03/23 Berenberg Infineon price target raised to EUR 44 from EUR 40 at Berenberg 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31 11/14/22 Infineon 'significantly' increases long-term financial targets 11/14/22 Infineon reports Q4 adjusted EPS EUR0.63 vs. EUR0.49 last year 10/22/22 Infineon dodging semiconductor collapse, chips for cars are key, Barron's says 02/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
On The Fly
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 01/17/23 Privia Health announces launches of ACOs in Delaware and North Carolina 12/05/22 NeoGenomics names Jeffrey Sherman as new CFO 11/15/22 Privia Health announces Butler resigned from board of directors 10/03/22 Director of Privia Health sold 80,853 shares of company stock $107.96 / -2.045 (-1.86%)
01/09/23 Xenon Pharmaceuticals outlines key milestone opportunities for 2023 01/09/23 Voyager, Neurocrine enter collaboration to advance multiple gene therapies 12/22/22 Neurocrine: FDA accepts sNDA for valbenazine 12/06/22 Neurocrine announces NBI-827104 did not meet its primary endpoint in Phase 2 $188.78 / +35.675 (+23.30%)
02/01/23 Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B 02/01/23 Meta says 2023 will be 'a year of efficiency' 02/01/23 Meta Platforms announces $40B increase in share repurchase authorization 02/01/23 Meta Platforms reports FoA and RL segment restructuring charges 01/17/23 Lightspeed announces reorganization, 10% workforce reduction 12/30/22 Lightspeed announces Saintil to step down from board of directors 12/29/22 Lightspeed rises 7.8% 12/06/22 Lightspeed names Kady Srinivasan as Chief Marketing Officer 02/02/23 Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake 01/25/23 Nordstrom Default Rating downgraded to junk by Fitch 01/19/23 Nordstrom falls 7% to $16.27 after cutting FY22 outlook 01/19/23 Nordstrom cuts FY22 EBIT margin view to 2.8%-3.1% from 4.1%-4.4% 01/24/23 International Paper to sell ownership in Ilim joint venture for $484M 12/06/22 Herbalife Nutrition falls -19.5% 12/06/22 Herbalife Nutrition falls -16.6% 12/06/22 Herbalife Nutrition falls -15.0% 12/05/22 Herbalife Nutrition falls 10% to $15.70 after offering $250M in convertible debt 09/26/22 H.B. Fuller names Celeste Mastin as new CEO 09/21/22 H.B. Fuller narrows FY22 adjusted EBITDA view to $540M-$550M from $530M-$550M 02/02/23 Ford sees FY23 capital expenditures $8B-$9B 02/02/23 Ford down 6% after Q4 earnings report 02/02/23 Ford declares regular Q1 dividend of 15c, supplemental dividend of 65c 02/02/23 Ford reports January U.S. sales up 2% to 146,356 vehicles 02/02/23 Enphase Energy demonstrates bidirectional EV charger technology 01/30/23 Enphase Energy expands solar deployments in Brazil 01/26/23 Enphase, Enerix to expand solar, battery storage product offerings in Europe 01/17/23 Enphase Energy expands IQ8 microinveter deployments in the Netherlands DAWN Day One Biopharmaceuticals 01/08/23 Day One announces top line data from pivotal Phase 2 FIREFLY-1 trial 10/17/22 Day One Biopharmaceuticals announces CRADA with NCI for tovorafenib 09/12/22 Day One Biopharmaceuticals appoints Nicholson as chairman 12/19/22 Cardinal Health announces Aaron Alt as chief financial officer 12/12/22 Yellow Corp appoints Annlea Rumfola as CIO 11/14/22 Elliott made Triple Flag Precious Metals top holding during Q3 09/15/22 PayrHealth announces collaboration with Cardinal Health $209.24 / -5.265 (-2.45%)
02/01/23 Boeing awarded $1.62B Air Force contract 02/01/23 Atlas Air takes delivery of final 747 to be produced by Boeing 01/31/23 Atlas Air takes delivery of Boeing's final 747 production aircraft 01/30/23 Boeing awarded U.S. Air Force contract for 15 KC-46A tankers AGIO Agios Pharmaceuticals 12/11/22 Agios Pharmaceuticals presents updated PYRUKYND long-term extension data 12/11/22 Agios Pharmaceuticals presents updated PYRUKYND data 12/06/22 Agios Pharmaceuticals appoints Tsveta Milanova as CCO 11/03/22 Agios Pharmaceuticals expects cash to fund operations through catalysts 02/03/23 UBS International Paper upgraded to Neutral from Sell at UBS 02/03/23 UBS International Paper upgraded to Neutral from Sell at UBS 02/02/23 Argus International Paper price target raised to $50 from $43 at Argus 02/01/23 Truist International Paper price target raised to $38 from $30 at Truist $209.24 / -5.265 (-2.45%)
02/03/23 RBC Capital Boeing downgraded to Sector Perform from Outperform at RBC Capital 01/30/23 Jefferies Boeing price target raised to $250 from $240 at Jefferies 01/26/23 Morgan Stanley Boeing remains a 'show me story,' says Morgan Stanley 01/12/23 Credit Suisse Credit Suisse upgrades Boeing to Neutral, raises price target to $200 02/03/23 Credit Suisse Lightspeed downgraded to Neutral from Outperform at Credit Suisse 02/02/23 CIBC Lightspeed downgraded to Neutral from Outperformer at CIBC 01/25/23 BofA Lightspeed initiated with a Neutral at BofA 01/25/23 BofA Lightspeed initiated with a Neutral at BofA 02/03/23 Craig-Hallum Synaptics price target raised to $150 from $120 at Craig-Hallum 02/03/23 Susquehanna Synaptics price target raised to $145 from $115 02/03/23 Oppenheimer Synaptics downgraded to Perform from Outperform at Oppenheimer 02/03/23 TD Cowen Synaptics price target raised to $150 from $100 at Cowen 02/03/23 William Blair Nordstrom performance 'begs for an activist role,' says William Blair 02/03/23 Gordon Haskett Nordstrom upgraded to Hold from Reduce at Gordon Haskett 01/30/23 Goldman Sachs Nordstrom initiated with a Neutral at Goldman Sachs 01/20/23 Deutsche Bank Nordstrom price target lowered to $17 from $21 at Deutsche Bank 02/03/23 Baird Baird upgrades Cardinal Health, sees 'value trap label' ending 02/03/23 Baird Cardinal Health upgraded to Outperform from Neutral at Baird 01/31/23 UBS Cardinal Health price target raised to $91 from $78 at UBS 11/22/22 Credit Suisse Cardinal Health price target raised to $79 from $64 at Credit Suisse $188.78 / +35.675 (+23.30%)
02/03/23 DA Davidson Amazon.com price target raised to $134 from $114 at DA Davidson 02/03/23 HSBC Meta Platforms downgraded to Reduce from Hold at HSBC 02/03/23 DZ Bank Meta Platforms upgraded to Hold from Sell at DZ Bank 02/02/23 Deutsche Bank Meta Platforms price target raised to $200 from $125 at Deutsche Bank 02/03/23 Benchmark Ford price target lowered to $19 from $21 at Benchmark 02/03/23 Deutsche Bank Deutsche downgrades Ford to Sell on 'meaningful' earnings risk 02/03/23 Deutsche Bank Ford downgraded to Sell from Hold at Deutsche Bank 01/25/23 JPMorgan Ford price target lowered to $15 from $16 at JPMorgan DAWN Day One Biopharmaceuticals 02/02/23 Oppenheimer Day One Biopharmaceuticals initiated with a Perform at Oppenheimer 01/09/23 H.C. Wainwright Day One Biopharmaceuticals price target raised to $45 from $35 at H.C. Wainwright 01/08/23 Piper Sandler Day One Biopharmaceuticals price target raised to $45 from $40 at Piper Sandler 12/15/22 H.C. Wainwright Day One Biopharmaceuticals initiated with a Buy at H.C. Wainwright 02/03/23 BofA Herbalife Nutrition initiated with an Underperform at BofA 11/01/22 B. Riley Herbalife Nutrition price target lowered to $31 from $38 at B. Riley 11/01/22 Citi Herbalife Nutrition price target lowered to $26 from $30 at Citi 10/05/22 Citi Herbalife Nutrition price target lowered to $30 from $36 at Citi AGIO Agios Pharmaceuticals 02/03/23 Piper Sandler Agios Pharmaceuticals initiated with an Overweight at Piper Sandler 11/17/22 Goldman Sachs Agios Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs 07/27/22 SVB Securities Agios Pharmaceuticals upgraded to Outperform from Market Perform at SVB Securities 02/25/22 RBC Capital Agios Pharmaceuticals price target raised to $67 from $61 at RBC Capital $107.96 / -2.045 (-1.86%)
02/03/23 Morgan Stanley Neurocrine upgraded to Overweight from Equal Weight at Morgan Stanley 12/13/22 RBC Capital Neurocrine CAH data appears pushed back, says RBC Capital 11/14/22 Evercore ISI Neurocrine downgraded to In Line from Outperform at Evercore ISI 11/02/22 BMO Capital Neurocrine price target raised to $101 from $78 at BMO Capital 02/03/23 Citi H.B. Fuller upgraded to Buy from Neutral at Citi 01/23/23 Citi H.B. Fuller price target raised to $72 from $65 at Citi 01/20/23 Deutsche Bank H.B. Fuller price target raised to $78 from $72 at Deutsche Bank 01/20/23 Baird H.B. Fuller price target lowered to $80 from $85 at Baird 02/03/23 Truist Enphase Energy price target lowered to $285 from $325 at Truist 02/03/23 Janney Montgomery Scott Enphase Energy initiated with a Neutral at Janney Montgomery Scott 02/01/23 Barclays SolarEdge price target lowered to $392 from $396 at Barclays 02/01/23 Barclays Enphase Energy price target lowered to $251 from $311 at Barclays 02/03/23 Goldman Sachs Privia Health initiated with a Buy at Goldman Sachs 01/17/23 Piper Sandler Piper Sandler would be a buyer of Privia Health following CMS data 01/09/23 BTIG Privia Health price target lowered to $40 from $45 at BTIG 12/08/22 Stifel Privia Health initiated with a Buy at Stifel 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31 11/10/22 Privia Health raises FY22 revenue view to $1.3B-$1.335B from $1.225B-$1.3B 11/10/22 Privia Health reports Q3 adjusted EPS 13c, consensus 0c 08/11/22 Privia Health sees 2022 revenue at high end of $1.225B-$1.3B 08/11/22 Privia Health reports Q2 adjusted EPS 13c vs. 9c last year. $107.96 / -2.045 (-1.86%)
11/01/22 Neurocrine reports Q3 non-GAAP EPS $1.08, consensus 79c 08/04/22 Neurocrine reports Q2 non-GAAP EPS 84c, consensus 15c $188.78 / +35.675 (+23.30%)
02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 02/02/23 Lightspeed sees FY23 revenue at low end of $730M-$740M, consensus $733.15M 02/02/23 Lightspeed reports Q3 adjusted EPS 0c, consensus (5c) 11/03/22 Lightspeed sees Q3 revenue at constant currency $189M-$194M, consensus $200.48M 11/03/22 Lightspeed reports Q3 adjusted EPS (5c), consensus (7c) 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 11/22/22 Nordstrom backs FY22 adjusted EPS view $2.30-$2.60, consensus $2.34 11/22/22 Nordstrom reports Q3 adjusted EPS 20c, consensus 14c 11/22/22 Notable companies reporting after market close 01/31/23 International Paper reports Q4 adjusted EPS 87c, consensus 69c 10/27/22 International Paper reports Q3 adjusted EPS $1.01, consensus $1.21 10/31/22 Herbalife Nutrition reports Q3 EPS 91c, consensus 74c 01/18/23 H.B. Fuller sees FY23 adjusted EPS $4.15-$4.55, consensus $4.63 01/18/23 H.B. Fuller reports Q4 adjusted EPS $1.04, consensus $1.24 09/21/22 H.B. Fuller sees Q4EPS $1.15-$1.30, consensus $1.28 09/21/22 H.B. Fuller reports Q3 EPS $1.06, consensus $1.04 02/02/23 Ford sees FY23 adjusted EBIT of $9B-$11B 02/02/23 Ford reports Q4 adjusted EPS 51c, consensus 62c 02/02/23 Notable companies reporting after market close 10/26/22 Ford reports Q3 adjusted EPS 39c, consensus 27c 10/25/22 Enphase Energy sees Q4 revenue $680M-$720M, consensus $660.21M 10/25/22 Enphase Energy reports Q3 EPS $1.25, consensus $1.08 10/25/22 Notable companies reporting after market close DAWN Day One Biopharmaceuticals 11/07/22 Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c) 08/04/22 Day One Biopharmaceuticals reports Q2 EPS (60c), consensus (49c) 02/02/23 Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40 02/02/23 Cardinal Health reports Q2 EPS $1.32, consensus $1.14 02/01/23 Notable companies reporting before tomorrow's open $209.24 / -5.265 (-2.45%)
01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c AGIO Agios Pharmaceuticals 11/03/22 Agios Pharmaceuticals reports Q3 EPS ($1.49), consensus ($1.76) 08/04/22 Agios Pharmaceuticals reports Q2 EPS ($1.68), consensus ($1.75)
Recommendations
Craig-Hallum analyst…
Craig-Hallum analyst Anthony Stoss raised the firm's price target on Synaptics to $150 from $120 and keeps a Buy rating on the shares. Synaptics reported weak results for the December quarter and guided below the Street for the March quarter, but March should be the low, the analyst tells investors in a research note.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 02/03/23 Susquehanna Synaptics price target raised to $145 from $115 02/03/23 Oppenheimer Synaptics downgraded to Perform from Outperform at Oppenheimer 02/03/23 TD Cowen Synaptics price target raised to $150 from $100 at Cowen 02/03/23 BMO Capital Synaptics price target raised to $135 from $90 at BMO Capital 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31
Recommendations
Susquehanna analyst…
Susquehanna analyst Christopher Rolland raised the firm's price target on Synaptics to $145 from $115 and keeps a Positive rating on the shares. The analyst said they reported weaker than expected results and guidance primarily as IoT performed below management expectations. Susquehanna believes Synaptics still remains in the "middle innings" of successfully executing a bona-fide turnaround and is deserving of a multiple re-rating when growth returns.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 02/03/23 Oppenheimer Synaptics downgraded to Perform from Outperform at Oppenheimer 02/03/23 TD Cowen Synaptics price target raised to $150 from $100 at Cowen 02/03/23 BMO Capital Synaptics price target raised to $135 from $90 at BMO Capital 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31
Downgrade
Oppenheimer analyst…
Oppenheimer analyst Martin Yang downgraded Synaptics to Perform from Outperform without a price target. The company's fiscal Q2 results significantly lagged Street estimates and management sees the inventory correction being sustained for two quarters for PC and Mobile, but lacks the visibility for timing the internet of things recovery, the analyst tells investors in a research note. With uncertain inventory conditions and weak end-market demand, Synaptics' outlook is dramatically reduced, contends the firm. Opco cites the uncertain timing regarding a revenue recovery and weaker margin outlook for the downgrade.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 02/03/23 TD Cowen Synaptics price target raised to $150 from $100 at Cowen 02/03/23 BMO Capital Synaptics price target raised to $135 from $90 at BMO Capital 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31
Recommendations
Cowen analyst Krish…
Cowen analyst Krish Sankar raised the firm's price target on Synaptics to $150 from $100 and keeps an Outperform rating on the shares. The analyst said guidance suggests increased weakness in IoT driven by enterprise budget cuts and continued weakness in consumer demand but the long-term thesis is fine.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 02/03/23 BMO Capital Synaptics price target raised to $135 from $90 at BMO Capital 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 11/04/22 Mizuho Synaptics price target lowered to $160 from $205 at Mizuho 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31
Recommendations
BMO Capital analyst…
BMO Capital analyst Ambrish Srivastava raised the firm's price target on Synaptics to $135 from $90 but keeps a Market Perform rating on the shares. The company's Q2 results and outlook missed expectations but still "faired relatively well" given the tough environment, the analyst tells investors in a research note. The firm also cites Synaptics guiding better margins despite the lower Internet of Things revenue. BMO notes however that the stock looks "reasonably valued at these levels".
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 11/04/22 Mizuho Synaptics price target lowered to $160 from $205 at Mizuho 10/31/22 TD Cowen Synaptics price target lowered to $110 from $210 at Cowen 02/02/23 Synaptics sees Q3 revenue $310M-$340M, consensus $365.38M 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31
Earnings
Sees Q3 gross margin…
Sees Q3 gross margin 60%-62%. Sees Q3 operating expense $98M-$102M.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 11/04/22 Mizuho Synaptics price target lowered to $160 from $205 at Mizuho 10/31/22 TD Cowen Synaptics price target lowered to $110 from $210 at Cowen 02/02/23 Synaptics reports Q2 EPS $2.20, consensus $2.34 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31 08/05/22 Synaptics sees Q1 revenue $440M-$470M, consensus $479.2M
Earnings
Reports Q2 revenue…
Reports Q2 revenue $353.1M, consensus $365.38M. "Given the macroeconomic environment, we are pleased with these results, particularly our ability to maintain margins. In terms of the product portfolio, we remain confident in our automotive, wireless, and video interface offerings. In each of these three areas, we showcased new products at CES, all of which increase our dollar per platform opportunity and should serve to both increase overall share and drive long-term growth for the company," said Michael Hurlston, Synaptics' president and CEO.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 11/04/22 Mizuho Synaptics price target lowered to $160 from $205 at Mizuho 10/31/22 TD Cowen Synaptics price target lowered to $110 from $210 at Cowen 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31 08/05/22 Synaptics sees Q1 revenue $440M-$470M, consensus $479.2M 08/05/22 Synaptics reports Q4 EPS $3.87, consensus $3.71
Conference/Events
Meeting to be held in New…
Meeting to be held in New York on January 9 hosted by Needham.
Show Hide Related Items >> <<
11/07/22 Synaptics senior VP McFarland sells 12,299 common shares 10/28/22 Synaptics acquires Emza Visual Sense, extends leadership position 11/04/22 BMO Capital Synaptics price target lowered to $90 from $110 at BMO Capital 11/04/22 Craig-Hallum Synaptics price target lowered to $120 from $180 at Craig-Hallum 11/04/22 Mizuho Synaptics price target lowered to $160 from $205 at Mizuho 10/31/22 TD Cowen Synaptics price target lowered to $110 from $210 at Cowen 11/03/22 Synaptics sees Q2 revenue $350M-$380M, consensus $448.22M 11/03/22 Synaptics reports Q1 EPS $3.52, consensus $3.31 08/05/22 Synaptics sees Q1 revenue $440M-$470M, consensus $479.2M 08/05/22 Synaptics reports Q4 EPS $3.87, consensus $3.71
